Continuous Subacromial Bupivacaine

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators wanted to re-evaluate the effects of subacromial bupivacaine infusion after shoulder arthroscopy with standard surgical techniques, including rotator cuff operations. The investigators hypothesized that patients having 5.0 mg/ml bupivacaine infusion at a rate of 2 ml/h subacromially would need less opioids than patients receiving a placebo infusion.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Turku University Hospital
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• subacromial impingement disease

• scheduled for an elective arthroscopic surgery

Exclusion Criteria:

• liver disease

• renal impairment

• psychiatric disorder

• alcohol abuse

• obesity (a body mass index of > 35 kg/m2)

• allergies to the drugs used in the study